Larimar Therapeutics Inc (LRMR) Income Statement

Total revenue

----

--0.00

Revenue

----

--0.00

Operating expenses

86.38%31.19M

120.96%31.29M

76.65%18.26M

155.71%24.60M

119.12%16.73M

35.66%14.16M

21.45%10.34M

10.74%9.62M

-14.07%7.64M

14.89%10.44M

-49.12%8.51M

-30.74%8.69M

-26.59%8.89M

-36.89%9.09M

61.88%16.73M

10.04%12.54M

240.73%12.11M

150.50%14.40M

16.29%10.34M

-6.49%11.40M

-73.24%3.55M

-60.88%5.75M

-41.41%8.89M

-21.66%12.19M

-15.44%13.28M

9.98%14.69M

18.14%15.17M

14.95%15.56M

18.37%15.70M

27.52%13.36M

-13.42%12.84M

-10.13%13.54M

-25.72%13.27M

-54.94%10.47M

-24.78%14.83M

-14.47%15.06M

34.87%17.86M

117.99%23.25M

37.30%19.72M

194.19%17.61M

192.86%13.24M

183.54%10.66M

307.52%14.36M

101.21%5.99M

28.44%4.52M

25.12%3.76M

--3.52M

--2.98M

--3.52M

--3.01M

R&D expenses

105.21%26.55M

151.11%26.74M

111.37%13.92M

235.01%19.68M

183.63%12.94M

47.52%10.65M

17.97%6.58M

4.09%5.88M

-21.43%4.56M

14.72%7.22M

-60.21%5.58M

-37.99%5.64M

-35.30%5.81M

-40.50%6.29M

102.75%14.03M

2.19%9.10M

9646.81%8.97M

2399.76%10.57M

31.54%6.92M

3.91%8.91M

-100.98%-94.00K

-96.31%423.00K

-55.54%5.26M

-29.79%8.57M

-22.54%9.63M

5.00%11.46M

21.67%11.83M

15.97%12.21M

28.48%12.43M

49.98%10.91M

-2.78%9.72M

3.59%10.53M

-22.57%9.68M

-58.91%7.28M

-29.43%10.00M

-18.86%10.16M

22.34%12.50M

141.06%17.71M

17.35%14.17M

166.79%12.53M

211.91%10.21M

191.12%7.34M

394.11%12.08M

139.42%4.70M

24.38%3.27M

4.95%2.52M

--2.44M

--1.96M

--2.63M

--2.40M

Depreciation, depletion, and amortization

0.00%100.00K

23.46%100.00K

0.00%100.00K

3.85%81.00K

0.00%100.00K

-11.36%78.00K

0.00%100.00K

76.00%88.00K

100.00%100.00K

--100.00K

31.58%100.00K

-35.90%50.00K

-35.06%50.00K

----

49.02%76.00K

-14.29%78.00K

-28.04%77.00K

9.62%57.00K

2.00%51.00K

82.00%91.00K

118.37%107.00K

8.33%52.00K

21.95%50.00K

-18.03%50.00K

0.00%49.00K

-7.69%48.00K

-18.00%41.00K

41.86%61.00K

276.92%49.00K

477.78%52.00K

900.00%50.00K

616.67%43.00K

225.00%13.00K

200.00%9.00K

66.67%5.00K

50.00%6.00K

--4.00K

0.00%3.00K

33.33%4.00K

----

--3.00K

Operating profit

-86.38%-31.19M

-120.96%-31.29M

-76.65%-18.26M

-155.71%-24.60M

-119.12%-16.73M

-35.66%-14.16M

-21.45%-10.34M

-10.74%-9.62M

14.07%-7.64M

-14.89%-10.44M

49.12%-8.51M

30.74%-8.69M

26.59%-8.89M

36.89%-9.09M

-61.88%-16.73M

-10.04%-12.54M

-240.73%-12.11M

-150.50%-14.40M

-16.29%-10.34M

6.49%-11.40M

73.24%-3.55M

60.88%-5.75M

41.41%-8.89M

21.66%-12.19M

15.44%-13.28M

-9.98%-14.69M

-18.14%-15.17M

-14.95%-15.56M

-18.37%-15.70M

-27.52%-13.36M

13.42%-12.84M

10.13%-13.54M

25.72%-13.27M

54.94%-10.47M

24.78%-14.83M

14.47%-15.06M

-34.87%-17.86M

-117.99%-23.25M

-37.30%-19.72M

-194.19%-17.61M

-192.86%-13.24M

-183.54%-10.66M

-307.52%-14.36M

-101.21%-5.99M

-28.44%-4.52M

-25.12%-3.76M

---3.52M

---2.98M

---3.52M

---3.01M

Net non-operating interest income (expenses)

Non-operating interest income

----

-59.81%258.00K

-50.37%335.00K

-27.61%451.00K

73.15%561.00K

140.45%642.00K

163.67%675.00K

134.21%623.00K

31.17%324.00K

17.62%267.00K

11.30%256.00K

15.65%266.00K

9.78%247.00K

8.61%227.00K

19.17%230.00K

60.84%230.00K

257.14%225.00K

435.90%209.00K

642.31%193.00K

14200.00%143.00K

6200.00%63.00K

--39.00K

--26.00K

--1.00K

--0.00

Non-operating interest expense

----

-39.80%301.00K

-27.45%362.00K

-10.32%426.00K

2.58%478.00K

9.17%500.00K

6137.50%499.00K

1432.26%475.00K

779.25%466.00K

527.40%458.00K

-91.75%8.00K

-76.52%31.00K

-62.14%53.00K

-54.37%73.00K

-46.11%97.00K

-34.00%132.00K

-34.27%140.00K

-24.88%160.00K

-15.09%180.00K

-6.10%200.00K

-51.92%213.00K

10550.00%213.00K

--212.00K

--213.00K

--443.00K

--2.00K

-100.00%0.00

--0.00

--57.00K

Gains from sale of securities

----

-1013.04%-210.00K

203.64%57.00K

28.26%-33.00K

69.86%-22.00K

136.51%23.00K

-320.00%-55.00K

-330.00%-46.00K

-1360.00%-73.00K

-163.00%-63.00K

125.77%25.00K

-65.52%20.00K

90.20%-5.00K

38.89%100.00K

-264.41%-97.00K

152.73%58.00K

-1375.00%-51.00K

224.14%72.00K

172.84%59.00K

5.17%-110.00K

-85.71%4.00K

-189.23%-58.00K

4.71%-81.00K

-680.00%-116.00K

117.39%28.00K

409.52%65.00K

-4350.00%-85.00K

--20.00K

---161.00K

---21.00K

--2.00K

Special income (expenses)

----

---10.00K

---1.53M

---4.02M

----

Other non-operating income (expenses)

-8.32%1.91M

111.21%2.47M

116.86%2.77M

137.00%2.97M

87.22%2.08M

15.29%1.17M

560.62%1.27M

6170.00%1.25M

2083.93%1.11M

2212.50%1.01M

357.33%193.00K

130.30%20.00K

-411.11%-56.00K

-125.00%-48.00K

-222.95%-75.00K

-195.65%-66.00K

-91.74%18.00K

--192.00K

--61.00K

--69.00K

--218.00K

----

Income before tax

-99.82%-29.28M

-121.84%-28.82M

-71.00%-15.50M

-158.51%-21.63M

-124.55%-14.65M

-37.86%-12.99M

-8.94%-9.06M

3.47%-8.37M

27.03%-6.53M

-3.19%-9.43M

50.49%-8.32M

31.26%-8.67M

26.02%-8.94M

35.69%-9.13M

-63.57%-16.80M

-11.29%-12.61M

-235.96%-12.09M

-95.89%-14.20M

20.44%-10.27M

6.59%-11.33M

72.56%-3.60M

50.23%-7.25M

14.29%-12.91M

23.11%-12.13M

17.82%-13.11M

-11.35%-14.57M

-19.72%-15.07M

-18.19%-15.78M

-22.63%-15.96M

-25.35%-13.09M

14.24%-12.59M

11.19%-13.35M

26.64%-13.01M

54.95%-10.44M

26.20%-14.68M

15.36%-15.03M

-31.65%-17.74M

-112.00%-23.17M

-35.37%-19.88M

-177.44%-17.76M

-202.20%-13.47M

-184.22%-10.93M

-319.21%-14.69M

-104.08%-6.40M

-25.90%-4.46M

-25.65%-3.85M

---3.50M

---3.14M

---3.54M

---3.06M

Income tax

----

--0.00

----

--0.00

----

--0.00

----

--0.00

Income after tax

-99.82%-29.28M

-121.84%-28.82M

-71.00%-15.50M

-158.51%-21.63M

-124.55%-14.65M

-37.86%-12.99M

-8.94%-9.06M

3.47%-8.37M

27.03%-6.53M

-3.19%-9.43M

50.49%-8.32M

31.26%-8.67M

26.02%-8.94M

35.69%-9.13M

-63.57%-16.80M

-11.29%-12.61M

-235.96%-12.09M

-95.89%-14.20M

20.44%-10.27M

6.59%-11.33M

72.56%-3.60M

50.23%-7.25M

14.29%-12.91M

23.11%-12.13M

17.82%-13.11M

-11.35%-14.57M

-19.72%-15.07M

-18.19%-15.78M

-22.63%-15.96M

-25.35%-13.09M

14.24%-12.59M

11.19%-13.35M

26.64%-13.01M

54.95%-10.44M

26.20%-14.68M

15.36%-15.03M

-31.65%-17.74M

-112.00%-23.17M

-35.37%-19.88M

-177.44%-17.76M

-202.20%-13.47M

-184.22%-10.93M

-319.21%-14.69M

-104.08%-6.40M

-25.90%-4.46M

-25.65%-3.85M

---3.50M

---3.14M

---3.54M

---3.06M

Net income from continuous operations

-99.82%-29.28M

-121.84%-28.82M

-71.00%-15.50M

-158.51%-21.63M

-124.55%-14.65M

-37.86%-12.99M

-8.94%-9.06M

3.47%-8.37M

27.03%-6.53M

-3.19%-9.43M

50.49%-8.32M

31.26%-8.67M

26.02%-8.94M

35.69%-9.13M

-63.57%-16.80M

-11.29%-12.61M

-235.96%-12.09M

-95.89%-14.20M

20.44%-10.27M

6.59%-11.33M

72.56%-3.60M

50.23%-7.25M

14.29%-12.91M

23.11%-12.13M

17.82%-13.11M

-11.35%-14.57M

-19.72%-15.07M

-18.19%-15.78M

-22.63%-15.96M

-25.35%-13.09M

14.24%-12.59M

11.19%-13.35M

26.64%-13.01M

54.95%-10.44M

26.20%-14.68M

15.36%-15.03M

-31.65%-17.74M

-112.00%-23.17M

-35.37%-19.88M

-177.44%-17.76M

-202.20%-13.47M

-184.22%-10.93M

-319.21%-14.69M

-104.08%-6.40M

-25.90%-4.46M

-25.65%-3.85M

---3.50M

---3.14M

---3.54M

---3.06M

Non-recurring net income

----

--0.00

----

Net income attributable to controlling interests

-99.82%-29.28M

-121.84%-28.82M

-71.00%-15.50M

-158.51%-21.63M

-124.55%-14.65M

-37.86%-12.99M

-8.94%-9.06M

3.47%-8.37M

27.03%-6.53M

-3.19%-9.43M

50.49%-8.32M

31.26%-8.67M

26.02%-8.94M

35.69%-9.13M

-63.57%-16.80M

-11.29%-12.61M

-235.96%-12.09M

-95.89%-14.20M

20.44%-10.27M

6.59%-11.33M

72.56%-3.60M

50.23%-7.25M

14.29%-12.91M

23.11%-12.13M

17.82%-13.11M

-11.35%-14.57M

-19.72%-15.07M

-18.19%-15.78M

-22.63%-15.96M

-25.35%-13.09M

14.24%-12.59M

11.19%-13.35M

26.64%-13.01M

54.95%-10.44M

26.20%-14.68M

15.36%-15.03M

-31.65%-17.74M

-112.00%-23.17M

-35.37%-19.88M

-175.59%-17.76M

-198.91%-13.47M

-180.35%-10.93M

-312.96%-14.69M

-101.97%-6.44M

-25.40%-4.51M

-26.34%-3.90M

---3.56M

---3.19M

---3.59M

---3.09M

Preferred share dividend

----

--0.00

----

--0.00

-100.00%0.00

-20.37%43.00K

-7.55%49.00K

112.00%53.00K

--53.00K

--54.00K

--53.00K

--25.00K

Net income attributable to common shareholders

-99.82%-29.28M

-121.84%-28.82M

-71.00%-15.50M

-158.51%-21.63M

-124.55%-14.65M

-37.86%-12.99M

-8.94%-9.06M

3.47%-8.37M

27.03%-6.53M

-3.19%-9.43M

50.49%-8.32M

31.26%-8.67M

26.02%-8.94M

35.69%-9.13M

-63.57%-16.80M

-11.29%-12.61M

-235.96%-12.09M

-95.89%-14.20M

20.44%-10.27M

6.59%-11.33M

72.56%-3.60M

50.23%-7.25M

14.29%-12.91M

23.11%-12.13M

17.82%-13.11M

-11.35%-14.57M

-19.72%-15.07M

-18.19%-15.78M

-22.63%-15.96M

-25.35%-13.09M

14.24%-12.59M

11.19%-13.35M

26.64%-13.01M

54.95%-10.44M

26.20%-14.68M

15.36%-15.03M

-31.65%-17.74M

-112.00%-23.17M

-35.37%-19.88M

-175.59%-17.76M

-198.91%-13.47M

-180.35%-10.93M

-312.96%-14.69M

-101.97%-6.44M

-25.40%-4.51M

-26.34%-3.90M

---3.56M

---3.19M

---3.59M

---3.09M

Basic earnings per share

-67.30%-0.46

-52.61%-0.45

-17.66%-0.24

-77.86%-0.34

-84.06%-0.27

-38.46%-0.30

44.84%-0.21

59.67%-0.19

69.52%-0.15

57.06%-0.21

59.27%-0.37

40.04%-0.47

35.47%-0.49

43.88%-0.50

-42.97%-0.92

34.73%-0.79

34.42%-0.76

61.90%-0.89

84.50%-0.64

69.03%-1.21

72.67%-1.15

50.62%-2.33

16.01%-4.15

43.22%-3.90

39.34%-4.22

17.47%-4.71

10.15%-4.94

-17.51%-6.87

-21.78%-6.95

-24.63%-5.71

14.74%-5.49

11.62%-5.84

26.87%-5.71

55.10%-4.58

26.69%-6.45

16.17%-6.61

-23.69%-7.81

-78.21%-10.21

-13.26%-8.79

-112.28%-7.89

-142.81%-6.31

-154.73%-5.73

-278.41%-7.76

-101.98%-3.72

-25.40%-2.60

-26.34%-2.25

---2.05

---1.84

---2.07

---1.78

Diluted earnings per share

-67.30%-0.46

-52.61%-0.45

-17.66%-0.24

-77.86%-0.34

-84.06%-0.27

-38.46%-0.30

44.84%-0.21

59.67%-0.19

69.52%-0.15

57.06%-0.21

59.27%-0.37

40.04%-0.47

35.47%-0.49

43.88%-0.50

-42.97%-0.92

34.73%-0.79

34.42%-0.76

61.90%-0.89

84.50%-0.64

69.03%-1.21

72.67%-1.15

50.62%-2.33

16.01%-4.15

43.22%-3.90

39.34%-4.22

17.47%-4.71

10.15%-4.94

-17.51%-6.87

-21.78%-6.95

-24.63%-5.71

14.74%-5.49

11.62%-5.84

26.87%-5.71

55.10%-4.58

26.69%-6.45

16.17%-6.61

-23.69%-7.81

-78.21%-10.21

-13.26%-8.79

-112.28%-7.89

-142.81%-6.31

-154.73%-5.73

-278.41%-7.76

-101.98%-3.72

-25.40%-2.60

-26.34%-2.25

---2.05

---1.84

---2.07

---1.78

Dividend per share

--0.00

Currency unit

USD

Audit opinions

--

Larimar Therapeutics Inc

3.225USD

Larimar Therapeutics Inc

3.225

Overview

Company

Financials

Statements

Income Statement

Balance Sheet

Cash Flow Statement